Journal of Viral Hepatitis

Papers
(The H4-Index of Journal of Viral Hepatitis is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Issue Information50
Age, ethnicity and proximity to clinic determine retention in care of chronic hepatitis B patients41
Response to letter to editor: Potential impact of Helicobacter pylori infection on hepatic steatosis and metabolic risk factors among patients with chronic hepatitis B39
31
Retraction26
Issue Information26
Correlates of chronic hepatitis B virus infection in the general adult population of China: Systematic review and meta‐analysis23
Bocavirus Infection as a Potential Trigger for Hepatic Injury in Children23
Screening, Prevalence and Management of Chronic Viral Hepatitis C in Mental Health Setting: Towards the Eradication of A Forgotten Reservoir22
Single‐Cell Transcriptome Identifies a Proinflammatory B‐Cell Subset in Hepatitis B Virus Associated Acute‐on‐Chronic Liver Failure21
Falling treatment uptake in the hepatitis C care cascade is a growing threat to achieving elimination20
Baseline Alpha‐Fetoprotein Elevation and the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B: A Multicentre Cohort Study20
Investigating rates and risk factors for hepatitis C virus reinfection in people receiving antiviral treatment in England20
A morphometric analysis of hepatitis B subviral particles shows no correlation of filament proportion and length with clinical stage and genotype19
Cover Image19
19
Efficacy of hepatitis C virus eradication after curative treatment for hepatocellular carcinoma in patients with advanced hepatocellular carcinoma and decreased hepatic functional reserve: A nationwid18
Depletion of circ_0088046 suppressed cell growth and motility of hepatocellular carcinoma via circ_0088046‐miR‐1299‐RTKN2 ceRNA pathway17
Kinetics of quantitative hepatitis B surface antigen in patients with rheumatic disease and chronic hepatitis B receiving biologic agents17
0.097148895263672